Thrombolysis and acute myocardial infarction

The Lancet

Volumn 343, Issue 8891, 1994, Pages 232-233

  Woods, K L ^a,b   Ketley, D ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; BLEEDING; BLOOD CLOT LYSIS; CONTROLLED STUDY; HUMAN; LETTER; PATIENT CARE; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0027979737     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)91016-2     Document Type: Letter

References (2)

1. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2
2. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy